Form 4: Drugs Made In America Acquisition Corp. Director Increases Stake with $300,000 Investment

Lynn Stockwell, Director, CEO, and Executive Chair of Drugs Made In America Acquisition Corp., reports acquiring 30,000 private units for $300,000, increasing her indirect holdings.

Summary

• Lynn Stockwell, the CEO, Executive Chair of the Board, and a Director of Drugs Made In America Acquisition Corp. (DMAA), has reported a transaction involving the acquisition of securities.
• On February 18, 2025, Ms. Stockwell, through Drugs Made In America Acquisition LLC (the Issuer's sponsor), acquired 30,000 private units at a price of $10 per unit, totaling $300,000.
• Each private unit consists of one ordinary share and one right to receive one-eighth (1/8) of an ordinary share upon the consummation of an initial business combination.
• Following this transaction, Ms. Stockwell indirectly beneficially owns 4,188,780 ordinary shares and 430,000 rights to receive ordinary shares.
• Ms. Stockwell disclaims beneficial ownership of the securities held by the sponsor, except to the extent of her pecuniary interest therein.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. A director increasing their stake in the company is generally viewed favorably, but the disclaimer of beneficial ownership tempers the enthusiasm.

Positives

• A director's investment of $300,000 in the company may signal confidence in the company's future prospects.

Future Outlook

The rights to receive ordinary shares will convert automatically upon the completion of the Issuer's initial business combination.

Management Comments

• Ms. Stockwell disclaims any beneficial ownership of the securities held by the sponsor, except to the extent of her pecuniary interest therein.

Industry Context

This filing is typical for corporate insiders who are required to disclose changes in their beneficial ownership of company securities, providing transparency to investors.

Stakeholder Impact

• The increased stake of a key insider could positively influence investor confidence.

Key Dates

Keywords

beneficial ownership, Form 4, DMAA, Drugs Made In America Acquisition Corp., Lynn Stockwell, private units, ordinary shares, rights, acquisition